Several considerations in using traditional Chinese patent medicine for cerebral infarction
暂无分享，去创建一个
[1] Yanming Xie,et al. [Post-marketing re-evaluation about usage and dosage of Chinese medicine based on human population pharmacokinetics]. , 2011, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.
[2] Shou-liang Zhao,et al. [Survey of root canal curvature of anterior teeth from Chuang population]. , 2009, Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology.
[3] Bo Wu,et al. Meta-Analysis of Traditional Chinese Patent Medicine for Ischemic Stroke , 2007, Stroke.
[4] V. Feigin. Herbal medicine in stroke: does it have a future? , 2007, Stroke.
[5] S. Vale. Subarachnoid haemorrhage associated with Ginkgo biloba , 1998, The Lancet.
[6] M. Matthews. Association of Ginkgo biloba with intracerebral hemorrhage , 1998, Neurology.
[7] J. Rowin,et al. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion , 1996, Neurology.
[8] Zhu Lin-feng. On Safety Risk Factors of Chinese Patent Medicine , 2011 .
[9] Gao Yu-zhong. On syndrome differentiation and treatment of fibromyalgia syndrome , 2010 .
[10] Li Tao. Some of problems in inclusion criteria and evaluation indexes of clinical trials in traditional herbs medicine for patients with cerebral infarction , 2005 .
[11] ANDUZE ACHER,et al. [Spontaneous bilateral subdural hematoma developing under the mask of migraine]. , 1959, Revue d'oto-neuro-ophtalmologie.